BioSpace News Archive

IRRAS announced the launch of its Hummingbird® ICP Monitoring product family in the United States.

FSD Pharma Inc. announces that Nasdaq has approved its application to have its Class B Subordinate Voting Shares listed on the Nasdaq Capital Market.

Demonstrated rapid, durable, and statistically significant improvement in depressive symptoms as measured by MADRS total score compared to placebo (p=0.002 on primary endpoint)

LTTS felicitated at 8th Foundation Day of Global Innovation & Technology Alliance

Humana Inc. (NYSE: HUM) today announced it has signed a definitive agreement to acquire privately held Enclara Healthcare (Enclara), one of the nation’s largest hospice pharmacy and benefit management providers, from Consonance Capital Partners and Enclara management.

In an update released today by CENTOGENE (Nasdaq: CNTG) to CentoMD® - the Company’s data repository of epidemiologic, phenotypic, and clinical data, - since September 2019 the number of analyzed cases has grown by 11% to more than 400,000, and the number of total variants has increased to 12.2 million from across 120 countries.

Elekta Unity MR-Linac cleared for diffusion-weighted images to assess tumor response paving the way toward a new era of personalized radiotherapy

On 16 December, the world’s leading healthcare ecosystem platform, Ping An Healthcare and Technology Company Limited announced that the Company and Thailand’s largest healthcare group Bangkok Dusit Medical Services jointly launched the overseas video consultation service for second opinions.

NeuroVive Pharmaceutical AB announced that it has fully and finally settled the dispute with CicloMulsion AG regarding certain pharmaceutical technology.

Algernon Pharmaceuticals Inc. is pleased to announce that Dr. Martin Kolb, a leading global scientific expert and clinician in the area of idiopathic pulmonary fibrosis, has joined the Algernon Medical and Scientific Advisory Board.